Evidence map›Paper›PMID 32634134›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Chlamydial-Secreted Protease Chlamydia High Temperature Requirement Protein A (cHtrA) Degrades Human Cathelicidin LL-37 and Suppresses Its Anti-Chlamydial Activity.

Xiaohua Dong, Wanxing Zhang, Jianmei Hou, Miaomiao Ma, Congzhong Zhu, Huiping Wang, Shuping Hou

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Pathogenic and Protective Roles of Neutrophils inPathogens (Basel, Switzerland) · 2025
    Review
  4. Insights into innate immune cell evasion byFrontiers in immunology · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xiaohua DongHebei Key Laboratory of Neuropharmacology, Hebei North University, Zhangjiakou, Hebei, China (mainland).
Wanxing ZhangDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China (mainland).
Jianmei HouDepartment of Pharmacy, Chinese Traditional Medicine Hospital of Lanling County, Linyi, Shandong, China (mainland).
Miaomiao MaDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China (mainland).
Congzhong ZhuDepartment of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China (mainland).
Huiping WangDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China (mainland).
Shuping HouDepartment of Dermatovenereology, Tianjin Medical University General Hospital, Tianjin, China (mainland).
Tianjin Medical University General Hospital · CNHebei North University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Chlamydia trachomatis is an obligate intracellular pathogen that can cause severe reproductive tract complications while ascending infection occurs. When spreading from cell to cell in a host, C. trachomatis utilizes various survival strategies to offset host defense mechanisms. One such strategy is to degrade host antimicrobial defense proteins before they can attack the invading C. trachomatis cells. MATERIAL AND METHODS We expressed and purified recombinant chlamydia high temperature requirement protein A (cHtrA) including 2 cHtrA mutants (MT-H143A and MT-S247A), and also extracted endogenous cHtrA. Proteins were identified and their purity evaluated by SDS-PAGE and Western blot. The anti-chlamydial activity and degradation of 5 antimicrobial peptides (cathelicidin LL-37, alpha-defensin-1 and -3, and ß-defensin-2 and -4) by cHtrA and 2 cHtrA mutants (MT-H143A and MT-S247A) were tested by immunoassay and Western blot. RESULTS Of the 5 antimicrobial peptides (cathelicidin LL-37, alpha-defensin-1 and -3, and ß-defensin-2 and -4) tested, cathelicidin LL-37 showed the strongest anti-chlamydial activity. Interestingly, cHtrA effectively and specifically degraded LL-37, suppressing its anti-chlamydial activity. The 2 cHtrA mutants (MT-H143A and MT-S247A) were unable to degrade LL-37. Comparison of cHtrA activity from C. trachomatis D, L2, and MoPn strains on LL-37 showed similar responses. CONCLUSIONS cHtrA may contribute to C. trachomatis pathogenicity by clearing the passage of invasion by specific LL-37 degradation.

Indexed as

Anti-Infective AgentsAntimicrobial Cationic PeptidesCathelicidinsChlamydia trachomatisEndopeptidasesEpithelial CellsHeLa CellsHigh-Temperature Requirement A Serine Peptidase 1HumansImmunologic FactorsPeptide HydrolasesSerine EndopeptidasesSerine ProteasesStaphylococcal Protein ATemperatureAnti-Infective AgentsAntimicrobial Cationic PeptidesCathelicidinsEndopeptidasesHigh-Temperature Requirement A Serine Peptidase 1Immunologic FactorsPeptide HydrolasesSerine EndopeptidasesSerine ProteasesStaphylococcal Protein A

Identifiers

PMID32634134
PMCPMC7366784
OpenAlexW3041475326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.